CureSign vs TrialJectory
CureSign vs TrialJectory, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CureSign is on 23/100 and TrialJectory on 58/100.
Where each one leads
CureSign
Leads on none of the measures we hold for both companies.
TrialJectory
- our overall score: 58/100 against 23/100
- domain rating: 39/100 against 7/100
- headcount: 17 against 4
- LinkedIn following: 4,387 against 78
At a glance
| Measure | CureSign | TrialJectory |
|---|---|---|
| What it is | Medical device company developing advanced sensor technology for oncology treatment. | AI-powered platform connecting cancer patients to advanced treatments and clinical trials. |
| Category | Healthcare, Sensor, Clinical, Oncology | Healthcare, Clinical Trials, Cancer, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware, Software | Software |
| Founded | 2016 | 2017 |
| Headquarters | Not published | New York, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | CureSign | TrialJectory |
|---|---|---|
| Employees | 4 | 17 |
| Headcount growthLast 12 months | Not published | -33.1% |
| Total funding | Not published | $39.7M |
| Latest round | Seed | Series A |
| LinkedIn followers | 78 | 4,387 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CureSign | TrialJectory |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 23/100 | 58/100 |
| Traction | 7/100 | 51/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 22/100 | 36/100 |
| Quality | Not published | 62/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 7/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CureSign | TrialJectory |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Tailwind CSS | Next.js |
CureSign vs TrialJectory: common questions
Which is better, CureSign or TrialJectory?
On our 0-100 score TrialJectory rates higher (58/100 against 23/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do CureSign and TrialJectory compare on the numbers?
TrialJectory leads on our overall score (58/100 against 23/100), domain rating (39/100 against 7/100), headcount (17 against 4), LinkedIn following (4,387 against 78).
Read the full CureSign review and pricing or the TrialJectory review and pricing. You can also browse other CureSign alternatives we track.